MA50630A - Procédé de préparation de dérivés d'alpha-carboxamide de pyrrolidine - Google Patents

Procédé de préparation de dérivés d'alpha-carboxamide de pyrrolidine

Info

Publication number
MA50630A
MA50630A MA050630A MA50630A MA50630A MA 50630 A MA50630 A MA 50630A MA 050630 A MA050630 A MA 050630A MA 50630 A MA50630 A MA 50630A MA 50630 A MA50630 A MA 50630A
Authority
MA
Morocco
Prior art keywords
pyrrolidine
alpha
preparation
carboxamide derivatives
carboxamide
Prior art date
Application number
MA050630A
Other languages
English (en)
Inventor
Weirong Chen
Vinny Couming
Erwin Irdam
William F Kiesman
Daw-Long A Kwok
Wenli Liang
Tamera L Mack
Suzanne M Opalka
Daniel B Patience
Donald G Walker
Original Assignee
Biogen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogen Inc filed Critical Biogen Inc
Publication of MA50630A publication Critical patent/MA50630A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/401—Proline; Derivatives thereof, e.g. captopril
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
MA050630A 2017-10-05 2018-10-05 Procédé de préparation de dérivés d'alpha-carboxamide de pyrrolidine MA50630A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201762568651P 2017-10-05 2017-10-05

Publications (1)

Publication Number Publication Date
MA50630A true MA50630A (fr) 2021-03-31

Family

ID=65995302

Family Applications (1)

Application Number Title Priority Date Filing Date
MA050630A MA50630A (fr) 2017-10-05 2018-10-05 Procédé de préparation de dérivés d'alpha-carboxamide de pyrrolidine

Country Status (12)

Country Link
US (2) US11192856B2 (fr)
EP (1) EP3691634A4 (fr)
JP (1) JP2020536870A (fr)
KR (1) KR20200061381A (fr)
CN (1) CN112153968A (fr)
AU (2) AU2018346763A1 (fr)
CA (1) CA3076823A1 (fr)
IL (1) IL273639B2 (fr)
MA (1) MA50630A (fr)
MX (1) MX2020003811A (fr)
SG (2) SG11202002706XA (fr)
WO (1) WO2019071162A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112153968A (zh) 2017-10-05 2020-12-29 生物基因公司 制备α-羧酰胺吡咯烷衍生物的工艺

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3164597A (en) 1962-12-17 1965-01-05 Geigy Chem Corp 5-carboxylic acid-2-phenyl-pyrrolines, corresponding pyrrolidines and functional derivatives thereof
CH674205A5 (fr) 1988-05-11 1990-05-15 Lonza Ag
IL94466A (en) 1989-05-25 1995-01-24 Erba Carlo Spa Pharmaceutical preparations containing the history of A-amino carboxamide N-phenylalkyl are converted into such new compounds and their preparation
US6201016B1 (en) 1994-06-27 2001-03-13 Cytomed Incorporated Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
GB9618349D0 (en) 1996-09-03 1996-10-16 Pharmacia Spa N-substituted 2-amino-4-phenyl-4-oxo-butanoic acid derivatives with kynurenine-3-hydroxylase inhibitory activity
IT1290910B1 (it) 1997-02-03 1998-12-14 Sigma Tau Ind Farmaceuti 2-amminotetralina otticamente attiva, procedimento per la sua preparazione e composizioni farmaceutiche che la contengono, attive
GB9727523D0 (en) 1997-12-31 1998-02-25 Pharmacia & Upjohn Spa Alpha-aminoamide derivatives useful as analgesic agents
ES2345921T3 (es) 1999-03-26 2010-10-06 Euro-Celtique S.A. Pirazoles, imidazoles, oxazoles, tiazoles y pirroles sustituidos con arilo y su uso.
GB9923748D0 (en) 1999-10-07 1999-12-08 Glaxo Group Ltd Chemical compounds
IT1317049B1 (it) 2000-06-23 2003-05-26 Sigma Tau Ind Farmaceuti Composti utili per la preparazione di medicamenti ad attivita'inibitrice della fosfodiesterasi iv.
GB0115517D0 (en) 2001-06-25 2001-08-15 Ferring Bv Novel antidiabetic agents
TWI286132B (en) 2002-09-20 2007-09-01 Hoffmann La Roche 4-pyrrolidino-phenyl-benzyl ether derivatives
MY142651A (en) 2003-03-18 2010-12-15 Merck Sharp & Dohme Biaryl substituted triazoles as sodium channel blockers
CA2520804A1 (fr) 2003-04-03 2004-10-28 Merck & Co., Inc. Pyrazoles biaryle substitue utilises en tant que bloqueurs de canaux sodiques
US20070060584A1 (en) 2003-04-18 2007-03-15 Chakravarty Prasun K Biaryl substituted thiazoles, oxazoles and imidazoles as sodium channel blockers
WO2005000309A2 (fr) 2003-06-27 2005-01-06 Ionix Pharmaceuticals Limited Composes chimiques
EP1524265A1 (fr) 2003-10-15 2005-04-20 Newron Pharmaceuticals S.p.A. Dérivés de prolinamide en tant que bloqueurs du canal sodium et/ou calcium ou inhibiteurs sélectifs de MAO-B
WO2005110982A2 (fr) 2004-04-07 2005-11-24 Neurogen Corporation Analogues substitues 1-benzyl-4-substitues piperazine
WO2005100334A1 (fr) 2004-04-14 2005-10-27 Pfizer Products Inc. Inhibiteurs de dipeptidyl peptidase-iv
WO2006119390A1 (fr) 2005-05-04 2006-11-09 Vertex Pharmaceuticals Incorporated Pyridines utiles en tant que modulateurs de canaux ioniques
JP2008540443A (ja) 2005-05-04 2008-11-20 バーテックス ファーマシューティカルズ インコーポレイテッド イオンチャネルのモジュレーターとして有用なピリミジンおよびピラジン
WO2006124865A2 (fr) 2005-05-19 2006-11-23 Vertex Pharmaceuticals Incorporated Biaryles utiles en tant que modulateurs des canaux ioniques
US7683056B2 (en) 2005-09-09 2010-03-23 Glaxosmithkline Llc Pyridine derivatives and their use in the treatment of psychotic disorders
ATE472529T1 (de) 2005-10-10 2010-07-15 Glaxo Group Ltd Prolinamidderivate als natriumkanalmodulatoren
TW200730494A (en) 2005-10-10 2007-08-16 Glaxo Group Ltd Novel compounds
TW200728258A (en) 2005-10-10 2007-08-01 Glaxo Group Ltd Novel compounds
WO2007123269A1 (fr) * 2006-04-19 2007-11-01 Astellas Pharma Inc. DÉRIVÉ d'azolecarboxamide
JP2007290973A (ja) * 2006-04-21 2007-11-08 Univ Nagoya 亜鉛−マグネシウムアート錯体を含む求核試薬及びそれを使用する求核付加体の製造方法
GB0701365D0 (en) 2007-01-24 2007-03-07 Glaxo Group Ltd Novel pharmaceutical compositions
JP2010516731A (ja) 2007-01-24 2010-05-20 グラクソ グループ リミテッド ２−メトキシ−５−（５−トリフルオロメチル−テトラゾール−１−イル）−ベンジル］−（２ｓ−フェニル−ピペリジン−３ｓ−イル）−アミンを含む医薬組成物
GB0701366D0 (en) 2007-01-24 2007-03-07 Glaxo Group Ltd Novel pharmaceutical compositions
GB0706630D0 (en) 2007-04-04 2007-05-16 Glaxo Group Ltd Novel compounds
PL2477964T3 (pl) 2009-09-14 2015-08-31 Convergence Pharmaceuticals Proces wytwarzania pochodnych alfa-karboksyamidu
US20110144081A1 (en) * 2009-12-15 2011-06-16 Henner Knust Pyrrolidine derivatives
WO2011155337A1 (fr) 2010-06-11 2011-12-15 シャープ株式会社 Dispositif à cristaux liquides
ES2428439T1 (es) 2010-11-11 2013-11-07 Aarti Healthcare Limited Un procedimiento para la preparación de Ramipril
ES2912881T3 (es) * 2014-12-23 2022-05-30 Convergence Pharmaceuticals Procedimiento para preparar derivados de alfa-carboxamida pirrolidina
WO2016160574A2 (fr) 2015-03-27 2016-10-06 Scifluor Life Sciences, Inc. Composés d'aryl-et hétéroaryl-pyrrolidine-2-carboxamide
CN106467513A (zh) * 2016-09-30 2017-03-01 陕西科技大学 一种制备Niraparib的合成方法
CN112153968A (zh) 2017-10-05 2020-12-29 生物基因公司 制备α-羧酰胺吡咯烷衍生物的工艺
KR20210150527A (ko) 2019-04-10 2021-12-10 바이오젠 엠에이 인코포레이티드 알파-카르복스아미드 피롤리딘 유도체 제조 방법
AU2020272878A1 (en) 2019-04-10 2021-12-02 Biogen Inc. Processes for preparing alpha-carboxamide pyrrolidine derivatives

Also Published As

Publication number Publication date
IL273639B1 (en) 2023-03-01
US11192856B2 (en) 2021-12-07
KR20200061381A (ko) 2020-06-02
EP3691634A4 (fr) 2021-03-31
US20220356154A1 (en) 2022-11-10
CA3076823A1 (fr) 2019-04-11
CN112153968A (zh) 2020-12-29
IL273639B2 (en) 2023-07-01
US20200270206A1 (en) 2020-08-27
SG11202002706XA (en) 2020-04-29
AU2018346763A1 (en) 2020-04-16
SG10202112966SA (en) 2021-12-30
IL273639A (en) 2020-05-31
WO2019071162A3 (fr) 2020-03-26
MX2020003811A (es) 2021-01-15
JP2020536870A (ja) 2020-12-17
EP3691634A2 (fr) 2020-08-12
WO2019071162A2 (fr) 2019-04-11
AU2023204011A1 (en) 2023-07-13

Similar Documents

Publication Publication Date Title
EP3677589A4 (fr) Procédé amélioré de production d'un conjugué anticorps-médicament
MA49752A (fr) Procédés de préparation de composés de pyrrolidine
EP3658552A4 (fr) Procédé amélioré pour la préparation de dérivés d'aminopyrimidine
EP3606533A4 (fr) Procédé de préparation de dérivés sulfonylcarbamate d'acides biliaires
MA51988A (fr) Procédé pour la préparation de composés utiles à traiter l'amyotrophie spinale
MA49472A (fr) Procédé de préparation d'intermédiaire de dérivé de 4-méthoxypyrrole
EP3766869A4 (fr) Procédé simple de préparation d'avibactam
MA50517A (fr) Procédé de préparation d'intermédiaire de dérivé de 4-méthoxypyrrole
EP3696168A4 (fr) Procédé de préparation de 2-chloro-5-trifluorométhylpyridine
EP3511313A4 (fr) Procédé de préparation de 1,3-cyclohexanediméthanol
EP3717016A4 (fr) Procédé pour la préparation de composés coupleurs de médicaments
EP3505525A4 (fr) Procédé de préparation de rubusoside
EP3981753A4 (fr) Procédé de préparation de triphénylchlorométhane
EP3902792A4 (fr) Procédé de préparation d'anthranilamides
MA51510A (fr) Procédés de préparation de dérivés d'indolinobenzodiazépine
EP3727377A4 (fr) Procédé de préparation de composés pyrimidinyl-4-aminopyrazole
EP3666756A4 (fr) Procédé de préparation de lévétiracétam
EP3533856A4 (fr) Procédé de préparation d'hexadécahydropyrène
EP3733651A4 (fr) Procédé de préparation de calcobutrol
EP3436439A4 (fr) Procédé de préparation de dérivés de diphénylpyrazine
EP3543236A4 (fr) Procédé de préparation d'un intermédiaire d'avibactam
EP3408252A4 (fr) Procédé de préparation de dérivés de prostacycline
EP3515915A4 (fr) Procédé de préparation d'intermédiaires d'hydroxyurée inhibiteurs des bêta-lactamases
EP3395786A4 (fr) Procédé de préparation de butadiène
EP4067341A4 (fr) Procédé de préparation de carbocistéine